Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01364207 · ClinicalTrials.gov registry record · NA
The Effects of Caffeinated Coffee on Intraocular Pressure
A NA study, sponsored by Massachusetts Eye and Ear Infirmary.
- Completed
- Registry status
- NA
- Development phase
- 112
- Enrollment target
NCT01364207 is a NA study that has completed, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 112 participants.
The verdict
NCT01364207, a NA study, has completed, sponsored by Massachusetts Eye and Ear Infirmary.
- COMPLETED
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
Study Summary
High intraocular pressure (IOP) is a known risk factor for developing primary open-angle glaucoma (POAG). There is controversy in the literature regarding the degree to which caffeine influences IOP, with some studies reporting minimal changes in IOP while others report up to 4 mmHg increases. To date there are no double-masked randomized controlled trials that examine acute caffeinated coffee's effects on IOP in patients with or at risk for primary open-angle glaucoma. The investigators aim to better understand the relationship between acute caffeinated coffee (vs decaffeinate coffee) consumption and IOP in a double-masked, crossover randomized controlled clinical trial.
Interventions
- OTHER Caffeinated Coffee
- OTHER Decaffeinated Coffee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2010-11 |
| Est. Completion | 2012-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01364207
The ClinicalTrials.gov registry entry for NCT01364207 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts Eye and Ear Infirmary, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Caffeinated Coffee is the first listed.
NCT01364207 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01364207 about?
NCT01364207 is a clinical study titled "The Effects of Caffeinated Coffee on Intraocular Pressure". High intraocular pressure (IOP) is a known risk factor for developing primary open-angle glaucoma (POAG). There is controversy in the literature regarding the degree to which caffeine influences IOP, with some studies reporting minimal changes in IOP while others report up to 4 mmHg increases. To da...
What is the current status of trial NCT01364207?
This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2010-11. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01364207?
The interventions under investigation include: Caffeinated Coffee (OTHER), Decaffeinated Coffee (OTHER).
Who is sponsoring clinical trial NCT01364207?
This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.